2012-03-15 16:58:22
The reference “Evaluation of HUBI-QUANpro Point-Of-Care Testing for Cardiac Markers” has been published.
The clinical study, “Evaluation of HUBI-QUANpro Point-Of-Care Testing for Cardiac Markers” performed at Catholic Lab Development and Evaluation Center, Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea) has been published on “Journal of Laboratory Medicine x-and Quality Assurance.”
The journal reports that HUBI-QUANpro CK-MB and BNP showed good analytical performances compared with the other two assays, ADVIA Centaur (Siemens, Germany) and Triage(Alere, USA).
Although the linearity range of cTnI was narrow, its agreement rate with ADVIA Centaur was good, thus the HUBI-QUANPRO assay could be useful as a quantitative POCT for cardiac markers in the emergency department.
This journal shows that the next-generation immunoassay equipment developed by domestic technology has reached the global stx-andard and technology.